Skip to main content

Table 4 Dosimetric paraneters

From: Ten fraction hypofractionated stereotactic body radiotherapy for the management of ultracentral lung tumors: a retrospective analysis of dosimetry, outcomes, and toxicity

Characteristic

Entire patient cohort (N = 78)

No prior in-field radiotherapy (N = 50)

Re-irradiation (N = 28)

p-value

PTV volume (cc): median (range)

66.6 (9.3–1201.8)

89.3 (9.3–1201.8)

62.0 (12.2–210.7)

0.03

Dose fractionation (total dose in Gy/fraction)

   

0.21

 70/10

23 (29.5)

19

4

 

 65/10

22 (28.2)

12

10

 

 63/10

1 (1.3)

0

1

 

 60/10

6 (7.7)

3

3

 

 50/10

22 (28.2)

13

9

 

 42.5/10

1 (1.3)

1

0

 

 40/10

3 (3.8)

2

1

 

Dose (Gy): median (range)

65.0 (40–70)

65.0 (40–70)

64.0 (40–70)

0.23

BED10 (Gy): median (range)

107.25 (56–119)

107.25 (56–119)

104.97 (50–119)

0.17

Total lung

 V5 (%): median (IQR)

24.0 (15.0, 41.7)

27.4 (16.7, 41.7)

19.3 (11.6, 36.3)

0.17

 V20 (%): median (IQR)

8.0 (4.5, 17.2)

9.6 (5.2, 17.8)

7.8 (3.4, 11.0)

0.22

 V40 (%): median (IQR)

3.2 (1.3, 5.8)

4.1 (1.5, 6.5)

2.3 (1.1, 5.1)

0.15

 MLD (Gy): median (IQR)

11.5 (6.7,16.8)

12.3 (8.7, 18.7)

9.9 (4.7, 12.6)

0.01

Esophagus

 Dmax (Gy): median (IQR)

37.52 (24.4, 48.9)

41.6 (26.5, 52.9)

31.3 (21.3, 42.1)

0.09

 V40 (cc): median (IQR)

0 (0, 0.6)

0 (0, 0.7)

0 (0, 0.01)

0.1

Primary bronchial tree/Trachea

 Dmax (Gy): median (IQR)

59.9 (45.5, 75.2)

55.6 (42.1, 77.3)

64.0 (49.8, 73.3)

0.81

 V50 (cc): median (IQR)

0.96 (0, 3.86)

1.0 (0, 3.9)

1.0 (0, 3.2)

0.73

Great vessel

 Dmax (Gy): median (IQR)

68.2 (53.5, 76.6)

68.2 (47.1, 74.0)

69.2 (55.1, 77.5)

0.23

 V50 (cc): median (IQR)

3.53 (0.1, 9.7)

3.2 (0, 13.1)

4.2 (0.8, 5.9)

0.18

  1. PTV: planning target volume, cc: cubic centimeter, Gy: Gray, BED10: biologic effective dose, Vx: volume of tissue exposed to x Gy or more, Dmax: maximum dose, MLD: mean lung dose, IQR: interquartile range